FdaApplication
NDA 219878
Identifiers
- fda_app_no: NDA219878
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA AB |
| application_type | NDA |
| approval_date | 2026-05-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BAXFENDY | BAXDROSTAT | 2MG | TABLET;ORAL |
| BAXFENDY | BAXDROSTAT | 1MG | TABLET;ORAL |
2 products